CRP and metabolic dysfunction-associated steatotic liver disease: In the two-way MR analysis, 261 SNPs were identified (Supplementary Table 7), employing CRP as the exposure (ebi-a-GCST90018730 and ukb-d-30710_raw) and MAFLD as the outcome (ebi-a-GCST90091033 and finn-b-NAFLD).